모링가 지하부의 항혈전 활성
Anti-thrombosis Activities of the Root Extract of Moringa oleifera Lam
2
조회
0
다운로드
11
인용
0
참고문헌
키워드
초록
Moringa oleifera Lam (MOL) has been used as a traditional medicine to treat various cancers and inflammation. Whereas the bioactivities of the MOL leaf and seed are well reported, the study of the root is still rudimentary. In this study, the ethanol extract of MOL (EEMOL) and its subsequent organic solvent fractions were prepared and their anticoagulation activity in vitro and platelet aggregation inhibitory activity were evaluated. The EEMOL had negligible anticoagulation and strong platelet aggregation activities. However, the hexane and ethyl acetate fractions of EEMOL showed significant inhibition against thrombin, prothrombin, coagulation factors, and platelet aggregation, without hemolytic activity up to 1.0 mg/ml. Our results suggest that the active fractions of MOL root have potential as new anti-thrombosis agents.
Abstract
Moringa oleifera Lam (MOL) has been used as a traditional medicine to treat various cancers and inflammation. Whereas the bioactivities of the MOL leaf and seed are well reported, the study of the root is still rudimentary. In this study, the ethanol extract of MOL (EEMOL) and its subsequent organic solvent fractions were prepared and their anticoagulation activity in vitro and platelet aggregation inhibitory activity were evaluated. The EEMOL had negligible anticoagulation and strong platelet aggregation activities. However, the hexane and ethyl acetate fractions of EEMOL showed significant inhibition against thrombin, prothrombin, coagulation factors, and platelet aggregation, without hemolytic activity up to 1.0 mg/ml. Our results suggest that the active fractions of MOL root have potential as new anti-thrombosis agents.
참고문헌 (31)
- Morton JF, "The horseradish tree, Moringa pterigosperma (Moringaceae)", A boon to arid lands. Econ. Bot, 45, pp.318~333 (1991)
- Anwar F, "Analytical characterization of Moringa oleifera seed oil grown in temperate regions of Pakistan", J. Agric. Food Chem, 51, pp.6558~6563 (2003)
- Anwar F, "Moringa oleifera: a food plant with multiple medicinal uses", Phytother. Res, 21, pp.17~25 (2007)
- Mughal MH, "Improvement of drumstick (Moringa pterygosperma Gaertn.) – a unique source of food and medicine through tissue culture", Hamdard Med, 42, pp.37~42 (1999)
- Siddhuraju P, "Antioxidant properties of various solvent extracts of total phenolic constituents from three different agroclimatic origins of drumstick tree (Moringa oleifera Lam.) leaves", J. Agric. Food Chem, 51, pp.2144~2155 (2003)
- 최은주, "모링가 잎 열수 추출물을 첨가한 설기떡의 항산화, 이화학 및 관능 특성", 한국식품조리과학회지, 31(3), pp.335~343 (2015), 한국식품조리과학회
- 권유리, "추출용매에 따른 모링가(Moringa oleifera Lam.) 잎의 항산화 및 생리활성 효과", Food Science and Preservation, 21(6), pp.831~837 (2014), 한국식품저장유통학회
- Dangi SY, "Antihypertensive activity of the total alkaloids from the leaves of Moringa oleifera", Pharm Biol, 40(144), pp.144~148 (2002)
- Sreelatha S, "Antiproliferation and Induction of Apoptosis by Moringa oleifera leaf extract on human cancer cells", Food Chem. Toxicol, 6, pp.1270~1275 (2011)
- Arabshahi-Delouee S, "Moringa oleifera leaves as an inhibitor of human platelet aggregation", Pharm. Biol, 47, pp.734~739 (2009)
- Rajanandh MG, "Moringa oleifera Lam. a herbal medicine for hyperlipidemia: A preclinical report", Asian Pacific J. Tropical Disease, 2, pp.S790~S795 (2012)
- Caceres A, "Pharmacologic properties of Moringa oleifera: 2: Screening for antispasmodic, anti-inflammatory and diuretic activity", J. Ethnopharmacol, 36, pp.233~237 (1992)
- Gothai S, "Chemical composition of Moringa oleifera ethyl acetate fraction and its biological activity in diabetic human dermal fibroblasts", Pharmacogn. Mag, 13, pp.S462~S469 (2017)
- Moura MC, "Multi-effect of the water-soluble Moringa oleifera lectin against Serratia marcescens and Bacillus sp.: antibacterial, antibiofilm and anti-adhesive properties", J. Appl. Microbiol, 123, pp.861~874 (2017)
- Guevara AP, "An antitumor promoter from Moringa oleifera Lam", Mutat. Res, 440, pp.181~188 (1999)
- Hamza AA, "Ameliorative effects of Moringa oleifera Lam seed extract on liver fibrosis in rats", Food Chem. Toxicol, 48, pp.345~355 (2010)
- Mahajan SG, "Effect of Moringa oleifera Lam. seed extract on ovalbumin-induced airway inflammation in guinea pigs", Inhal. Toxicol, 20, pp.897~909 (2008)
- Bhatnagar M, "Hemostatic, antibacterial biopolymers from Acacia arabica (Lam.) Willd. and Moringa oleifera (Lam.) as potential wound dressing materials", Indian J. Exp. Biol, 51, pp.804~810 (2013)
- Luz Lde A, "Structural characterization of coagulant Moringa oleifera Lectin and its effect on hemostatic parameters", Int. J. Biol. Macromol, 58, pp.31~36 (2013)
- 박수현, "모링가 뿌리 추출물에 대한 신장섬유화 억제 효과", 생명과학회지, 22(10), pp.1371~1377 (2012), 한국생명과학회[DOI]
- 조현지, "유방암 세포주에서 PMA로 유도된 암세포 침투에 대한 모링가 뿌리 추출물의 억제효과", 생명과학회지, 24(1), pp.8~13 (2014), 한국생명과학회[DOI]
- 이효진, "HaCaT 각질형성세포에서 TNF-α에 의하여 유도되는 염증 발현에 대한 부위별 모링가 추출물의 억제 효과", 생명과학회지, 22(9), pp.1254~1260 (2012), 한국생명과학회[DOI]
- 안선미, "체리(Prunus avium L.)의 항균 및 항산화 활성", 한국미생물·생명공학회지, 37(4), pp.371~376 (2009), 한국미생물·생명공학회
- Singleton VL, "Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocaleau reagent", Methods Enzymol, 299, pp.152~178 (1999)
- Valentina U, "Sugars, organic acids, phenolic composition and antioxidant activity of sweet cherry (Prunus avium L.)", Food Chem, 107, pp.185~192 (2007)
- 정인창, "흑마늘의 항산화, 항균 및 항혈전 활성", 한국미생물·생명공학회지, 42(3), pp.285~292 (2014), 한국미생물·생명공학회[DOI]
- 류희영, "33종 생약재의 in-vitro 항혈전 활성 평가", 생명과학회지, 20(6), pp.922~928 (2010), 한국생명과학회
- Chen H, "Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis", Thrombosis Res, 131, pp.173~177 (2013)
- Bijina B, "Protease inhibitor from Moringa oleifera with potential for use as therapeutic drug and as seafood preservative", Saudi Journal Biol. Sci, 18, pp.273~281 (2011)
- 김미선, "성숙 마가자의 혈액 응고저해 및 혈소판 응집저해 활성", 한국미생물·생명공학회지, 43(4), pp.373~377 (2015), 한국미생물·생명공학회[DOI]
- Sweeney JD, "Thrombocytopenia after desmopressin but absence of in-vitro hypersensitivity to ristocetin", Am. J. Clin. Path, 93, pp.522~525 (1990)